Morgan Stanley reissued an overweight rating for Vertex on June 22, 2026.
1 report, 1 independent
Updated Jun 22
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley reissued an overweight rating for Vertex on June 22, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Vertex
company
-
Morgan Stanley
U.S. investment bank
Related events
- Morgan Stanley began research coverage on Vertex Pharmaceuticals, raising its target price and giving it an overweight rating, alongside institutional filings.
- Morgan Stanley reaffirmed an overweight rating on AbbVie, and Barclays raised its price objective on September 10, 2026.
- Morgan Stanley lowered its rating for CAE Inc from equal weight to underweight on August 27, 2026.
- Morgan Stanley analyst provides Overweight rating for SpaceX.
- Morgan Stanley reissued an overweight rating for Wynn Resorts, which was reported by MarketBeat.